natgillin/translations-raw huggingface dataset:
Recent work by the OECD shows that regions close to cities tend to grow, while the more remote regions 49 tend to lose population. 
Novejši podatki OECD kažejo, da število prebivalcev regij v bližini mest običajno raste, v odročnejših regijah 49 pa upada.
It recovered somewhat in the 2000s and then roughly stabilised in the decade that followed. 
11 Po letu 2000 se je nekoliko povečalo, nato pa v naslednjem desetletju v glavnem stabiliziralo.
That is down to about 6% today, and is projected to fall to below 4% by 2070. 
Doslej se je zmanjšal na približno 6 %, do leta 2070 naj bi predvidoma padel pod 4 %.
The EU-27's working-age population has been shrinking for a decade and is projected to fall by 18% by 2070. 
Število delovno sposobnih prebivalcev v EU-27 se že desetletje zmanjšuje in bo do leta 2070 predvidoma upadlo za 18 %.
Between 2001 and 2018, the mean age of women at childbirth in the EU went from 29.0 to 30.8. 
Med letoma 2001 in 2018 se je v EU povprečna starost žensk ob rojstvu pomaknila od 29,0 na 30,8 leta.
Households by presence of children, EU-27, 2010-2019 (in millions) 
Gospodinjstva po številu otrok v EU-27, 2010-2019 (v milijonih)
The update of the Skills Agenda, and the recommendation on Vocational Education and Training, will also be important steps to achieve this. 
Pomembni ukrepi za doseganje tega cilja bodo posodobitev programa znanj in spretnosti ter priporočila za poklicno izobraževanje in usposabljanje.
As Europe gets older, a growing number of people aged 65 and above will live alone 17 . 
S staranjem Evrope se bo povečevalo število ljudi, starih 65 let in več, ki živijo sami.
Demographic change also has an impact on Europe's geopolitical outlook and position in the world. 
Demografske spremembe vplivajo tudi na geopolitično prihodnost in položaj Evrope v svetu.
EU-27 population by urban-rural regional typology, 2019 
Prebivalstvo EU-27 po tipologiji urbanih in podeželskih regij, 2019
In 2004, Europe accounted for 18.3% of the global GDP, shrinking to 14.3% in 2018 62 . 
Zmanjšuje se tudi delež Evrope v svetovnem BDP Leta 2004 je bil delež Evrope v svetovnem BDP 18,3 % in se je do leta 2018 zmanjšal na 14,3 %.
In 2018, 2.4 million people immigrated into the EU-27, while 1.1 million people emigrated to a non-EU-27 country 18 . 
Leta 2018 se je v EU-27 priselilo 2,4 milijona ljudi, 1,1 milijona ljudi pa se je izselilo v državo, ki ni članica EU-27.
In addition to that, insufficient digital skills and strong divergence in skills levels between countries and regions and a lack of accessibility might aggravate this divide. 
To vrzel lahko poslabšajo tudi nezadostna digitalna znanja in spretnosti, velike razlike med ravnmi znanja in spretnosti med državami in regijami ter pomanjkljiva dostopnost.
22% of the urban population lived in a region that lost population between 2014 and 2019. 
22 % mestnega prebivalstva je živelo na območju, kjer je med letoma 2014 in 2019 število prebivalcev upadlo.
This report presents the drivers of demographic change and the impact they are having across Europe 2 . 
V tem poročilu so predstavljeni ključni dejavniki demografskih sprememb in njihov vpliv na vso Evropo.
For the EU as a whole, the number of healthy life years at birth in 2018 was 64.2 years for women and 63.7 for men 8 . 
V EU kot celoti je bilo leta 2018 ob rojstvu predvideno število let zdravega življenja pri ženskah 64,2 leta, pri moških pa 63,7 leta 8 .
A lack of adequate formal long-term care services, of flexible working opportunities and of incentives for second earners in some Member States all play a part in accentuating this issue. 
V nekaterih državah članicah je na poudarjanje tega vprašanja vplivalo pomanjkanje ustreznih formalnih storitev dolgotrajne oskrbe, priložnosti za prožne zaposlitve in spodbud za prejemnike drugega dohodka v gospodinjstvih.
Over the last decade, it was decreasing slowly and by 2019, it was down to 2.3. 
V zadnjem desetletju se je velikost gospodinjstev počasi zmanjševala in se do leta 2019 znižala na 2,3 osebe.
In 2019, the share of older women living alone was 40%, more than double the figure for men. 
Leta 2019 je delež starejših žensk, ki živijo same, znašal 40 %, kar za več kot dvakrat presega ustrezni delež moških.
At the same time, the working-age population (20-64 years) 16 is projected to decrease. 
Obenem naj bi se predvidoma zmanjšal delež delovno sposobnih prebivalcev (20-64 let).
In 2018, in the EU-27, 15.5% of people aged 65 or above were at risk of poverty 42 . 
Leta 2018 je bilo v EU-27 15,5 % ljudi, starih 65 let ali več, izpostavljenih tveganju revščine.
Others are projected to see an initial growth followed by a decline, and these are Belgium, Czechia, Estonia, Spain, France, Germany, Netherlands, Austria, Portugal, Slovenia, Slovakia and Finland. 
Za ostale se predvideva, da bo število prebivalcev sprva naraslo, nato pa upadlo, in sicer so te države: Belgija, Češka, Estonija, Španija, Francija, Nemčija, Nizozemska, Avstrija, Portugalska, Slovenija, Slovaška in Finska.
While Belgium, Ireland, Cyprus, Luxembourg, Malta and Sweden have seen a relatively steady increase, Bulgaria, Croatia, Latvia, Lithuania and Romania have seen their population decline after 1990 19 . 
V Belgiji, na Irskem, Cipru, v Luksemburgu, na Malti in Švedskem število prebivalcev razmeroma enakomerno narašča, v Bolgariji, na Hrvaškem, v Latviji, Litvi in Romuniji pa po letu 1990 upada.
In eight Member States, rural regions have been losing population since 1991: the three Baltic States, Bulgaria, Croatia, Hungary, Portugal and Romania. 
V osmih državah članicah se je število prebivalcev v podeželskih regijah od leta 1991 zmanjševalo: v treh baltskih državah, Bolgariji, Hrvaški, Madžarski, Portugalski in Romuniji.
Change in the share of population aged 65 and over by region 29 , 2020-2030 
Sprememba deleža prebivalstva, starega 65 let in več, po regijah, 29 2020-2030
THE TWIN TRANSITIONS AND DEMOGRAPHIC CHANGE 
4DVOJNI PREHOD IN DEMOGRAFSKE SPREMEMBE
Different regions are affected differently by demographic change. 
Demografske spremembe različno vplivajo na različne regije.
Some are projected to experience population growth up to 2070: Denmark, Ireland, Cyprus, Luxembourg, Malta and Sweden. 
V nekaterih državah bo do leta 2070 število prebivalcev predvidoma naraščalo: Danska, Irska, Ciper, Luksemburg, Malta in Švedska.
Total population change by region 47 , 2011-2019 
Spremembe skupnega števila prebivalcev po regijah 47 , 2011-2019
Some Member States are projected to have a declining population over the entire period until 2070, namely Bulgaria, Greece, Croatia, Italy, Latvia, Lithuania, Hungary, Poland and Romania. 
V nekaterih državah članicah se bo število prebivalcev v celotnem obdobju do leta 2070 predvidoma zmanjševalo, in sicer v Bolgariji, Grčiji, na Hrvaškem, v Italiji, Latviji, Litvi, na Madžarskem, Poljskem in v Romuniji.
Life expectancy at birth by region 10 , 2018 
Pričakovana življenjska doba ob rojstvu po regijah, 10 2018
The new Comprehensive Strategy with Africa 63 is particularly important given the complementary demographic challenges our continents will face. 
Ob upoštevanju demografskih izzivov, ki so komplementarni izzivom, s katerimi se bodo srečevali naši kontinenti, je zlasti pomembna nova celovita strategija za Afriko.
From 2019 until 2070, the share of people aged 80 or over is projected to more than double to 13% 15 . 
Med letoma 2019 in 2070 naj bi se delež prebivalcev, starih 80 let in več, predvidoma povečal za več kot dvakrat, in sicer na 13 %.
Change in population aged 20-64 by region 21 , 2020-2030 
Spremembe števila prebivalcev v starosti 20-64 let po regijah 21 , 2020-2030
Total population and annual population change, EU-27, 1960-2070 
Skupno število prebivalcev in njegove letne spremembe v EU-27, 1960-2070
By 2070, 30% of people in Europe are estimated to be aged 65 and above, up from about 20% today. 
Po ocenah se bo do leta 2070 v Evropi delež prebivalcev, starih 65 let in več, s sedanjih približno 20 % povečal na 30 %.
Old-age poverty is likely to be a growing concern as demographic change continues. 
Zaradi demografskih sprememb bo revščina v starosti verjetno vse bolj zaskrbljujoča.
The situation for third-country nationals provides a similar picture. 
Podobno je tudi pri državljanih tretjih držav.
The population size and density of settlements decreases from urban, to intermediate and to rural regions. 
Število prebivalcev in gostota naselij sta največja v urbanih regijah, manjša v vmesnih regijah, najmanjša pa v podeželskih regijah.
In 2070, life expectancy at birth is projected 6 to reach 86.1 years for men, up from 78.2 in 2018. 
Pričakovana življenjska doba ob rojstvu za moške, ki je leta 2018 znašala 78,2 leta, naj bi se v letu 2070 predvidoma 6 povečala na 86,1 leta.
Regions that have a low income and suffer from rapid population change face the most challenging situation. 
Z najzahtevnejšimi razmerami se srečujejo regije z nizkimi dohodki in hitrimi spremembami števila prebivalcev.
For women, it is estimated at 90.3 - up from 83.7. 
Za ženske je znašala 83,7 leta in se bo po ocenah povečala na 90,3 leta.
Total fertility rate by region 13 , 2018 
Skupna stopnja rodnosti po regijah, 13 2018
World population by continent, 1960-2070 
Prebivalci sveta po celinah, 1960-2070
Working age population (20-64), EU-27, 2001-2070 
Delovno sposobno prebivalstvo (20-64) v EU-27, 2001-2070
Median age of the world population by continent, 1960-2070 
Mediana starosti svetovnega prebivalstva po celinah, 1960-2070
Fertility indicators, EU-27, 2001-2018 
Kazalniki rodnosti v EU-27, 2001-2018
Europe's population has grown consistently over time. 
Število prebivalcev v Evropi se nenehno povečuje.
Median age of EU-27 population, 2001-2070 
Mediana starosti prebivalstva EU-27, 2001-2070
5.Conclusion and next steps 
5.Zaključek in naslednji koraki
The same applies to the Member States of the European Economic Area (EEA). 
Enako velja za države članice Evropskega gospodarskega prostora (EGP).
All regions of the world are affected. 
Prizadete so vse regije sveta.
This makes the risk worth taking. 
Zato je vredno tvegati.
The EU recognises this task as its responsibility. 
EU priznava to nalogo kot svojo odgovornost.
Vaccine development usually takes more than 10 years. 
Razvoj cepiva običajno traja več kot 10 let.
There is a very real risk that none of the supported candidates will be successful. 
Obstaja zelo realno tveganje, da nobeden od podprtih kandidatov ne bo uspešen.
A truly European approach would avoid competition between Member States. 
Resnično evropski pristop bi preprečil konkurenco med državami članicami.
The EU Member States are closely interlinked. 
Države članice EU so med seboj tesno povezane.
The Commission will continue to support this global mobilisation and collaboration. 
Komisija bo še naprej podpirala to globalno mobilizacijo in sodelovanje.
The spread of the virus has shown that no region is safe until the virus is under control everywhere. 
Širjenje virusa je pokazalo, da nobena regija ni varna, dokler ni virus povsod pod nadzorom.
This will reduce the Commission's authorisation procedures from nine weeks to one. 
S tem se bodo postopki Komisije za pridobitev dovoljenja zmanjšali z devet tednov na enega.
The strategy has the following objectives: 
Cilji strategije so naslednji:
The EU will only be safe if the rest of the world is safe. 
EU bo varna le, če bo varen ves svet.
When taking the financing decision, the following non-exhaustive criteria will be taken into account: 
Pri sprejemanju sklepa o financiranju se bodo upoštevala naslednja neizčrpna merila:
It creates solidarity between all Member States, irrespective of the size of their population and their purchasing power. 
Ustvaril bi solidarnost med vsemi državami članicami, ne glede na velikost njihovega prebivalstva in njihovo kupno moč.
3.4.Legislation on genetically modified organisms 
3.4.Zakonodaja o gensko spremenjenih organizmih
The strategy rests on two pillars: 
Strategija temelji na dveh stebrih:
This is not only a European challenge, it is also a global one. 
To ni izziv samo za Evropo, ampak za cel svet.
These benefits will be increased if more countries were to join the common effort. 
Te prednosti se bodo povečale, če se bo skupnim prizadevanjem pridružilo več držav.
These products may fall under the definition of genetically modified organisms (GMOs) and are thus covered by the relevant EU legislation. 
Ti proizvodi lahko spadajo pod opredelitev gensko spremenjenih organizmov (GSO) in jih tako zajema ustrezna zakonodaja EU.
2.4.Additional support through loans from the European Investment Bank 
2.4.Dodatna podpora v obliki posojil Evropske investicijske banke
A second step is underway in partnership with Global Citizen and other governmental and non-governmental partners. 
Naslednji korak poteka v partnerstvu z organizacijo Global Citizen in drugimi vladnimi in nevladnimi partnerji.
The actions set out in this Communication contribute to this global response. 
Ukrepi iz tega sporočila prispevajo k temu globalnemu odzivu.
Joint action at EU level is the surest, quickest and most efficient way of achieving that objective. 
Skupno ukrepanje na ravni EU je najzanesljivejši, najhitrejši in najučinkovitejši način za doseganje tega cilja.
To this effect, it will deploy the regulatory, financial, advisory and other tools at its disposal. 
V ta namen bo uporabila regulativna, finančna, svetovalna in druga orodja, ki so ji na voljo.
3.1.Early engagement with EMA and international cooperation 
3.1.Zgodnje sodelovanje z EMA in mednarodno sodelovanje
The budgetary authorities, the European Parliament and the Council, have made EUR 2.7 billion available under the ESI. 
Proračunska organa, tj. Evropski parlament in Svet, sta v okviru ESI dala na voljo 2,7 milijarde evrov.
3.3.Flexibility in relation to labelling and packaging requirements 
3.3.Prožnost v zvezi z zahtevami glede označevanja in pakiranja
It will also enable us to combine the scientific and regulatory expertise of the Commission and the Member States. 
Omogočil nam bo tudi združitev znanstvenega in regulativnega strokovnega znanja Komisije in držav članic.
The development and deployment of tests and treatments therefore remain important. 
Zato so razvoj in uvajanje testov ter zdravljenja še naprej pomembni.
2.Support for vaccine development and production in the EU 
2.Podpora za razvoj in proizvodnjo cepiva v EU
The Commission and EMA will encourage vaccine producers to consider this possibility. 
Komisija in EMA bosta proizvajalce cepiv spodbudili k razmisleku o tej možnosti.
This is likely to cause significant delay, particularly for multi-centre clinical trials in several Member States. 
To bo verjetno povzročilo znatno zamudo, zlasti pri multicentričnih kliničnih preskušanjih v več državah članicah.
A pan-EU approach will increase the EU's leverage when negotiating with industry. 
Vseevropski pristop bo povečal vpliv EU v pogajanjih z industrijo.
Centralising vaccine procurement at EU level has the merit of speed and efficiency by comparison with 27 separate processes. 
Centralizacija javnega naročanja cepiv na ravni EU ima tudi prednost hitrosti in učinkovitosti v primerjavi s 27 ločenimi postopki.
The output of such production sites will not be reserved for the EU. 
Proizvodnja takih proizvodnih obratov ne bo namenjena samo za EU,
A common EU approach will always respect the principle of subsidiarity and Member States' competences in health policy: vaccination policies remain in the hands of Member States. 
Skupni pristop EU bo vedno spoštoval načelo subsidiarnosti ter pristojnosti držav članic na področju zdravstvene politike: politike cepljenja ostajajo v rokah držav članic.
The Single Market, allowing the free movement of goods and people, has allowed economies to integrate closely and has increased the interdependence of all our economies and societies. 
Enotni trg, ki omogoča prosti pretok blaga in ljudi, je omogočil tesno povezovanje gospodarstev ter povečal soodvisnost vseh naših gospodarstev in družb.
As the pandemic moves across borders, so its socio-economic impact on each of the Member States spreads to the others. 
Ko se pandemija širi čez meje, se tudi njen socialno-ekonomski učinek na posamezno državo članico razširi na druge.
·Ensuring the quality, safety and efficacy of vaccines. 
·zagotoviti kakovost, varnost in učinkovitost cepiv,
3.A flexible and robust regulatory process 
3.Prožen in trden regulativni postopek
The aim of the negotiations is to conclude Advance Purchase Agreements with individual companies under the best possible conditions. 
Cilj pogajanj je skleniti sporazume za vnaprejšnji nakup s posameznimi podjetji po najboljših možnih pogojih.
The strategy will seek synergies with other Union instruments to ensure full consistency and complementarity of Union actions. 
Strategija si bo prizadevala za sinergije z drugimi instrumenti Unije, da se zagotovita popolna skladnost in dopolnjevanje ukrepov Unije.
2.1.An EU approach for efficiency and solidarity 
2.1.Pristop EU za učinkovitost in solidarnost
This can greatly facilitate early availability of vaccines in low- and middle-income countries. 
To lahko zelo olajša zgodnjo razpoložljivost cepiv v državah z nizkim in srednjim dohodkom.
2.3.Selection criteria for vaccine candidates 
2.3.Merila za izbor kandidatov za cepivo
This immunisation framework draws on the expertise of Member States, the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO). 
Ta okvir za imunizacijo temelji na strokovnem znanju držav članic, Evropskega centra za preprečevanje in obvladovanje bolezni (ECDC) ter Svetovne zdravstvene organizacije (SZO).
The unprecedented circumstances in which the EU finds itself requires a bold response. 
Okoliščine, v katerih se je znašla EU, so brez primere in zahtevajo drzen odziv.
Under normal circumstances, packaging and labelling of authorised medicinal products, including vaccines, should be provided in all EU languages. 
V običajnih okoliščinah je treba pakiranje in označevanje odobrenih zdravil, vključno s cepivi, zagotoviti v vseh jezikih EU.
-Cost: amount of financing requested, the schedule and conditions of the related payments. 
-stroški: znesek zaprošenih finančnih sredstev, časovni okvir in pogoji za povezana plačila,
3.2.Accelerated procedure for authorisation 
3.2.Pospešeni postopek za odobritev
In order to clearly understand the scale of the vaccine needs in the EU, the Health Security Committee is advancing its work on an EU immunisation framework, as requested by the Health Council on 7 May. 
Da bi jasno razumeli obseg potreb po cepivu v EU, Odbor za zdravstveno varnost pospešeno dela na okviru EU za imunizacijo, kar je 7. maja zahteval Svet za zdravje.
-Global solidarity: a commitment to making future doses of vaccines available for partner countries to end the global pandemic. 
-globalna solidarnost: zaveza, da bodo odmerki cepiva v prihodnosti na voljo partnerskim državam, da bi končali svetovno pandemijo,
In the current crisis, teams around the world are working with the ambition of delivering a successful vaccine within a timeframe of 12 - 18 months. 
V sedanji krizi si ekipe po celem svetu prizadevajo razviti uspešno cepivo v časovnem okviru od 12 do 18 mesecev.
The Commission proposes to enter into an Agreement with participating Member States to formalise their reciprocal commitments. 
Komisija predlaga, da skupaj s sodelujočimi državami članicami sklene sporazum, s katerim bodo formalizirale svoje vzajemne obveznosti.
-Liability: what special liability coverage, if any, companies would require. 
-odgovornost: katero posebno zavarovanje odgovornosti bi podjetja morebiti zahtevala,
·Securing timely access to vaccines for Member States and their population while leading the global solidarity effort. 
·zagotoviti pravočasen dostop do cepiv za države članice in njihovo prebivalstvo ter imeti hkrati vodilno vlogo v globalnih solidarnostnih prizadevanjih,
The current proposal builds on the important groundwork undertaken by that Alliance. 
Sedanji predlog temelji na pomembnem pripravljalnem delu v okviru tega zavezništva.
Significant levels of EU support have already been made available to vaccine producers. 
Proizvajalcem cepiv so že na voljo znatne ravni podpore EU.
The COVID-19 pandemic is inflicting huge human and economic costs on the European Union and the world. 
Pandemija COVID-19 povzroča ogromne človeške in gospodarske izgube v Evropski uniji in v svetu.
In this way, the Commission will ensure that the EU continues to play its part in resolving the COVID-19 crisis for the world. 
Komisija bo tako zagotovila, da bo EU še naprej igrala svojo vlogo pri reševanju krize zaradi COVID-19 v svetu.
At the same time, EU citizens will want assurances that they will have access to any successful vaccine. 
Državljani EU bodo hkrati hoteli imeti zagotovila, da bodo imeli dostop do morebitnega uspešnega cepiva.
The Commission invites the European Parliament and Council to adopt the proposal swiftly in order to enable clinical trials to take place in Europe as soon as possible. 
Komisija poziva Evropski parlament in Svet, naj predlog hitro sprejmeta, da se čim prej omogoči izvajanje kliničnih preskušanj v Evropi.
These agreements will be negotiated with individual companies according to their specific needs and with the aim of supporting and securing an adequate supply of vaccines. 
Ti sporazumi bodo sklenjeni po pogajanjih s posameznimi podjetji v skladu z njihovimi specifičnimi potrebami ter s ciljem, da se podprejo in zagotovijo ustrezne zaloge cepiv.
Against that background, it is essential that all 27 EU Member States have access to a vaccine as early as possible. 
Glede na navedeno je nujno, da ima vseh 27 držav članic EU čim prej dostop do cepiva.
This process also offers vaccine producers a significantly simplified negotiation process with a single point of contact, thus reducing costs for all. 
Ta postopek tudi proizvajalcem cepiv omogoča znatno poenostavljen pogajalski proces z enotno kontaktno točko, kar bi zmanjšalo stroške za vse.
This is because developing a safe and effective vaccine is a highly complex process. 
To je zato, ker je razvoj varnega in učinkovitega cepiva zelo zapleten proces.
The scale of the crisis means that time pressure is unprecedented: every month gained in the deployment of a vaccine will save many lives, many jobs and many billions of euros. 
Zaradi razsežnosti krize je časovni pritisk brez primere: z vsakim mesecem, ki ga bomo pridobili pri uvajanju cepiva, bomo rešili veliko življenj, delovnih mest in milijard evrov.
This allows the EIB to offer highly attractive conditions on financial products offered for vaccine development and related manufacturing activities. 
To omogoča EIB, da ponudi zelo privlačne pogoje za finančne produkte, ki so na voljo za razvoj cepiv in s tem povezane proizvodne dejavnosti.
There is no guarantee that a safe and effective vaccine will be available soon. 
Nimamo nobenega zagotovila, da bo varno in učinkovito cepivo kmalu na voljo.
For this reason, the assistance of the steering board on any liability issues will be essential. 
Zato bo pri vseh vprašanjih v zvezi z odgovornostjo bistvenega pomena pomoč usmerjevalnega odbora.
The development of a vaccine within short deadlines creates a particular challenge for the authorisation process. 
Razvoj cepiva v kratkih rokih pomeni poseben izziv za postopek za odobritev.
No Member State on its own has the capacity to secure the investment in developing and producing a sufficient number of vaccines. 
Nobena država članica nima sama zmogljivosti, da bi zagotovila naložbe v razvoj in proizvodnjo zadostne količine cepiv.
This will facilitate and ultimately accelerate the development, assessment, authorisation and safety monitoring of vaccines. 
To bo olajšalo in v končni fazi pospešilo razvoj, ocenjevanje, odobritev in spremljanje varnosti cepiv.
In order to scale this approach up to cover the whole EU, the Commission proposes to run a central procurement process, which creates a number of important advantages. 
Da bi ta pristop razširili na celotno EU, Komisija predlaga izvedbo centralnega postopka javnega naročanja, kar bi imelo številne pomembne prednosti.